UBS Group AG grew its position in Amprius Technologies, Inc. (NYSE:AMPX – Free Report) by 35.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,098,946 shares of the company’s stock after acquiring an additional 549,892 shares during the period. UBS Group AG’s holdings in Amprius Technologies were worth $16,561,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of AMPX. Bank of America Corp DE raised its stake in shares of Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after acquiring an additional 3,055 shares during the last quarter. Quarry LP bought a new position in shares of Amprius Technologies in the third quarter valued at approximately $42,000. Rhumbline Advisers raised its stake in shares of Amprius Technologies by 61.1% in the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the last quarter. Legal & General Group Plc raised its stake in shares of Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after acquiring an additional 9,684 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in shares of Amprius Technologies in the second quarter valued at approximately $44,000. Institutional investors own 5.04% of the company’s stock.
More Amprius Technologies News
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Northland Securities raised its Q4 2027 EPS estimate for Amprius Technologies to $0.03 from $0.02, and also kept a constructive longer-term view with FY2028 EPS projected at $0.23, suggesting improving profitability ahead. HC Wainwright Has Bullish Forecast for AMPX FY2029 Earnings
- Positive Sentiment: Northland Securities also reiterated a favorable longer-term outlook by forecasting FY2028 EPS of $0.23, well above the current-year consensus of a loss, which may be helping investor sentiment. HC Wainwright Has Bullish Forecast for AMPX FY2029 Earnings
- Neutral Sentiment: Northland Securities lowered its Q2 2027 EPS estimate to $0.00 from $0.01, indicating some caution on the pace of near-term earnings growth. HC Wainwright Has Bullish Forecast for AMPX FY2029 Earnings
- Neutral Sentiment: HC Wainwright trimmed its FY2026 and FY2027 EPS estimates to losses or minimal profit, reflecting ongoing expectations that Amprius will remain in a development-and-scale-up phase before sustained earnings arrive. HC Wainwright Has Bullish Forecast for AMPX FY2029 Earnings
- Negative Sentiment: HC Wainwright cut its FY2028 EPS estimate to $0.18 from $0.20, a modest downgrade that signals slightly less optimism on the company’s long-range earnings power. HC Wainwright Has Bullish Forecast for AMPX FY2029 Earnings
Amprius Technologies Price Performance
Amprius Technologies (NYSE:AMPX – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Amprius Technologies had a negative return on equity of 17.48% and a negative net margin of 43.98%.The business had revenue of $28.54 million for the quarter, compared to analyst estimates of $25.72 million. On average, sell-side analysts expect that Amprius Technologies, Inc. will post -0.06 EPS for the current year.
Insider Buying and Selling at Amprius Technologies
In other Amprius Technologies news, Director Steven Chu sold 155,565 shares of Amprius Technologies stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the completion of the sale, the director owned 127,339 shares of the company’s stock, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Wen Hsuan Hsieh sold 413,146 shares of Amprius Technologies stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the sale, the director directly owned 44,444 shares of the company’s stock, valued at $819,547.36. This represents a 90.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,539,829 shares of company stock worth $42,323,376 over the last quarter. 5.10% of the stock is currently owned by insiders.
Analysts Set New Price Targets
AMPX has been the subject of a number of research analyst reports. B. Riley Financial lifted their target price on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, March 9th. Craig Hallum raised their price target on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a report on Friday, March 6th. Northland Securities set a $24.00 price target on shares of Amprius Technologies in a report on Monday. Needham & Company LLC reissued a “buy” rating and issued a $20.00 price target on shares of Amprius Technologies in a report on Tuesday, March 10th. Finally, Roth Mkm reissued a “buy” rating on shares of Amprius Technologies in a report on Friday. Eight analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Amprius Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $20.25.
Read Our Latest Research Report on AMPX
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Recommended Stories
- Five stocks we like better than Amprius Technologies
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPX – Free Report).
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
